Van Hulzen Asset Management, LLC Amgen Inc Transaction History

Van Hulzen Asset Management, LLC

$1.38 Billion
Q3 2024

A detailed history of Van Hulzen Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 11,968 shares of AMGN stock, worth $3.15 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

11,968

Previous 11,860 0.91%

Holding current value

$3.15 Million

Previous $3.71 Million 4.05%

% of portfolio

0.28%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $33,413 - $36,437	108 Added 0.91%	11,968 $3.86 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $498,962 - $606,369	-1,899 Reduced 13.8%	11,860 $3.71 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $70,981 - $85,683	264 Added 1.96%	13,759 $3.91 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $26,081 - $29,422	102 Added 0.76%	13,495 $3.89 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $400,785 - $497,586	-1,833 Reduced 12.04%	13,393 $3.6 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $11 Million - $13 Million	-51,221 Reduced 77.09%	15,226 $3.38 Million
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $3.94 Million - $4.8 Million	17,453 Added 35.62%	66,447 $16 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $2.67 Million - $3.39 Million	11,662 Added 31.24%	48,994 $12.8 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $6.12 Million - $6.9 Million	27,249 Added 270.25%	37,332 $8.42 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $24,224 - $26,957	105 Added 1.05%	10,083 $2.45 Million
Q1 2022 May 20, 2022	SELL	$219.27 - $242.57 $1.87 Million - $2.07 Million	-8,515 Reduced 46.04%	9,978 $2.41 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $65,232 - $74,652	328 Added 1.81%	18,493 $4.16 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $50,095 - $58,693	236 Added 1.32%	18,165 $3.86 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.01%	17,929 $4.37 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $979,066 - $1.14 Million	-4,412 Reduced 19.75%	17,928 $4.46 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $8,006 - $9,533	-37 Reduced 0.17%	22,340 $5.14 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $70,864 - $78,806	-302 Reduced 1.33%	22,377 $5.69 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $171,501 - $210,455	-867 Reduced 3.68%	22,679 $5.35 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $996,123 - $1.32 Million	5,466 Added 30.23%	23,546 $4.77 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $1.18 Million - $1.51 Million	6,227 Added 52.54%	18,080 $4.36 Million
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $1.43 Million - $1.71 Million	8,193 Added 223.85%	11,853 $2.29 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $160,198 - $187,789	961 Added 35.61%	3,660 $674,000
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $36,174 - $40,776	-200 Reduced 6.9%	2,699 $513,000
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $13,736 - $16,035	-77 Reduced 2.59%	2,899 $564,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $137,114 - $154,578	740 Added 33.09%	2,976 $617,000
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $277,635 - $311,844	-1,672 Reduced 42.78%	2,236 $413,000
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $487,619 - $569,844	-2,878 Reduced 42.41%	3,908 $666,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $421,975 - $471,475	2,500 Added 58.33%	6,786 $1.18 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $365,695 - $417,526	2,186 Added 104.1%	4,286 $799,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,100	2,100 $362,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.

Account

Van Hulzen Asset Management, LLC Amgen Inc Transaction History